financetom
Business
financetom
/
Business
/
Demesne Resources Completes First Payment to Buy Past-Producing Tungsten IMA Mine Project in Idaho
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Demesne Resources Completes First Payment to Buy Past-Producing Tungsten IMA Mine Project in Idaho
Nov 29, 2024 5:39 AM

08:20 AM EST, 11/29/2024 (MT Newswires) -- Demesne Resources ( DEMRF ) on Friday said it has completed the first payment to IMA-1 of US$100,000 to acquire a 100% interest in the IMA project, a past-producing underground tungsten mine in Idaho.

The company can acquire the property for US$5.8 million cash paid over eight years. The property is subject to a 2% royalty in favor of IMA-1.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Skechers Usa Insider Sold Shares Worth $1,905,968, According to a Recent SEC Filing
Skechers Usa Insider Sold Shares Worth $1,905,968, According to a Recent SEC Filing
Mar 5, 2024
04:57 PM EST, 03/05/2024 (MT Newswires) -- Robert Greenberg, 10% Owner, Director, Chief Executive Officer, on March 01, 2024, sold 31,202 shares in Skechers Usa ( SKX ) for $1,905,968. Following the Form 4 filing with the SEC, Greenberg has control over a total of 136,617 shares of the company, with 132,783 shares held directly and 3,834 controlled indirectly. SEC...
Avidity Biosciences Insider Sold Shares Worth $1,691,306, According to a Recent SEC Filing
Avidity Biosciences Insider Sold Shares Worth $1,691,306, According to a Recent SEC Filing
Mar 5, 2024
04:56 PM EST, 03/05/2024 (MT Newswires) -- Sarah Boyce, Director, President and CEO, on March 01, 2024, sold 84,000 shares in Avidity Biosciences ( RNA ) for $1,691,306. Following the Form 4 filing with the SEC, Boyce has control over a total of 112,117 shares of the company, with 112,117 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1599901/000159990124000038/xslF345X03/wk-form4_1709675574.xml Price: 19.52, Change: +0.38,...
Analog Devices Insider Sold Shares Worth $1,958,300, According to a Recent SEC Filing
Analog Devices Insider Sold Shares Worth $1,958,300, According to a Recent SEC Filing
Mar 5, 2024
04:57 PM EST, 03/05/2024 (MT Newswires) -- Vincent Roche, Director, Chair & CEO, on March 04, 2024, sold 10,000 shares in Analog Devices ( ADI ) for $1,958,300. Following the Form 4 filing with the SEC, Roche has control over a total of 60,713 shares of the company, with 5,713 shares held directly and 55,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/6281/000000628124000038/xslF345X03/wk-form4_1709675567.xml...
Orthofix Medical Q4 Loss Widens, Sales Rise; 2024 Sales Outlook Set
Orthofix Medical Q4 Loss Widens, Sales Rise; 2024 Sales Outlook Set
Mar 5, 2024
04:57 PM EST, 03/05/2024 (MT Newswires) -- Orthofix Medical ( OFIX ) reported a Q4 loss late Tuesday of $0.59 per diluted share, wider than a loss of $0.35 a year earlier. Four analysts surveyed by Capital IQ expected a loss of $0.49. Net sales for the quarter ended Dec. 31 were $200.4 million, up from $122.2 million a year...
Copyright 2023-2026 - www.financetom.com All Rights Reserved